221 related articles for article (PubMed ID: 1006894)
21. [On the suitability of "cytooncological" examinations for urological diagnosis].
Swiesiulski S
Pol Przegl Chir; 1969 Aug; 41(8):Suppl 8a:1132+. PubMed ID: 5343560
[No Abstract] [Full Text] [Related]
22. [Value of alpha-globulin as a biological tracer in urogenital cancer].
Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304
[No Abstract] [Full Text] [Related]
23. [Special problems of early detection of malignant tumors of the genito-urinary system (author's transl)].
Mebel M; Vogler H
Arch Geschwulstforsch; 1981; 51(8):679-84. PubMed ID: 6176207
[No Abstract] [Full Text] [Related]
24. [Significance of carcinoembryonic antigen (CEA) in urine and plasma in patients with urinary bladder carcinoma].
Hering H; Hering FJ; Weidner W
Med Welt; 1976 May; 27(19):920-2. PubMed ID: 1272056
[No Abstract] [Full Text] [Related]
25. [Carcino-embryonic antigen as screening protein in the follow-up of patients with surgically-treated gastrointestinal cancer (author's transl)].
Möschl P; Staritz C; Keiler A; Kreuzer W; Fasching W
Wien Klin Wochenschr; 1980 Feb; 92(4):128-30. PubMed ID: 7395229
[TBL] [Abstract][Full Text] [Related]
26. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Wechsler M; Gerfo PL; Feminella J; Lattimer JK
J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
[No Abstract] [Full Text] [Related]
27. [Carcino-embryonic antigen and beta 2 microglobulin in malignant bone diseases. 61 cases (author's transl)].
Trèves R; Clément A; Desproges-Gotteron R; Olivier JP; Beck C
Nouv Presse Med; 1982 Jan; 11(1):21-4. PubMed ID: 6173840
[TBL] [Abstract][Full Text] [Related]
28. Immunological evaluation in patients with urological cancers.
Martinez-Piñeiro JA; Muntanola P; Hidalgo L
Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
[TBL] [Abstract][Full Text] [Related]
29. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
[TBL] [Abstract][Full Text] [Related]
30. [Measurement of urine and serum CEA--a help in diagnosis and follow-up of bladder neoplasms].
Edsmyr F; Wahren B; Zimmerman R
Lakartidningen; 1975 Aug; 72(34):3141-2. PubMed ID: 1165691
[No Abstract] [Full Text] [Related]
31. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III.
Persijn JP; Korsten CB; Batterman JJ; Tierie AH; Renaud J
J Clin Chem Clin Biochem; 1976 Aug; 14(8):395-9. PubMed ID: 965893
[TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen (CEA) in the plasma and urine of patients with urologic cancer.
Thitipraserth A; Ablin R; Bush I; Guinan P
Proc Inst Med Chic; 1973; 29(9):323. PubMed ID: 4737044
[No Abstract] [Full Text] [Related]
33. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
[No Abstract] [Full Text] [Related]
34. Carcino-embryonic antigen activity in urine of patients with bladder carcinoma. Clinical evaluation of carcino-embryonic antigen. II.
Korsten CB; Persijn JP; Renaud J; Houtzager-Boelens CA
J Clin Chem Clin Biochem; 1976 Aug; 14(8):389-93. PubMed ID: 965892
[TBL] [Abstract][Full Text] [Related]
35. [Immunodiagnosis of urologic tumors].
Günther M; Friedrich A; Jenssen HL; Werner H; Köhler H; Seyfarth M; Erdmann T
Z Urol Nephrol; 1977 May; 70(4):225-30. PubMed ID: 331743
[TBL] [Abstract][Full Text] [Related]
36. [beta2-Microglobulin and carcino-embryonic antigen in bronchogenic carcinoma (author's transl)].
Bisset JP; Poirier R; Roux F; Sauvan R; Kleisbauer JP
Pathol Biol (Paris); 1978 Sep; 26(6):353-4. PubMed ID: 83583
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
38. Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder.
Alsabti EA; Saffo MH
Urol Int; 1979; 34(5):387-92. PubMed ID: 494440
[TBL] [Abstract][Full Text] [Related]
39. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report].
Takada T; Honda M; Momohara C; Komori K; Fujioka H
Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939
[TBL] [Abstract][Full Text] [Related]
40. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Arora B; Chhabra A; Yadav MS; Arora DR
Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
